Sartorius Stedim Biotech SA (STDM.PA) Quote| Reuters.com
Edition:
United States

Sartorius Stedim Biotech SA (STDM.PA)

STDM.PA on Paris Stock Exchange

62.19EUR
5:53am EDT
Change (% chg)

€1.21 (+1.98%)
Prev Close
€60.98
Open
€61.42
Day's High
€62.30
Day's Low
€61.39
Volume
12,093
Avg. Vol
49,702
52-wk High
€66.01
52-wk Low
€39.83

STDM.PA

Chart for STDM.PA

About

Sartorius Stedim Biotech SA is a France-based international provider of laboratory and process technologies and equipment. The Company covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and... (more)

Overall

Beta: 0.54
Market Cap(Mil.): €5,621.15
Shares Outstanding(Mil.): 92.18
Dividend: 0.33
Yield (%): 0.55

Financials

  STDM.PA Industry Sector
P/E (TTM): 41.45 41.77 35.71
EPS (TTM): 1.47 -- --
ROI: 17.98 11.63 14.23
ROE: 22.04 13.66 15.43

BRIEF-Sartorius Stedim Biotech unit's Glasgow facility passes FDA inspection

* Sartorius Stedim bioOutsource contract testing facility in Glasgow successfully passes FDA inspection Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Mar 02 2016

BRIEF-Sartorius Stedim Biotech proposes increased FY dividend

* To submit proposal to pay a dividend of EUR 2.00 per share for fiscal 2015, up from eur 1.30 a year earlier

Feb 25 2016

BRIEF-Sartorius Stedim Biotech FY EBITDA rises to 231.3 mln euro

* FY sales revenue of 884.3 million euro ($959.1 million), up 29.4 pct

Feb 01 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : MacroRisk Analytics/EconomicInvestor
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : Sadif Analytics Prime
$10.00
Provider : GlobalData
$300.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.